Every decision needs a compass.
For cancer treatment, it’s Polaris™

Polaris™
Our platform seamlessly links histology, RNASeq, and patient outcomes at scale, creating an integrated view of spatial biology that drives deeper insights and novel cancer biology discoveries1.
1. El Nahhas, O.S.M., van Treeck, M., Wölflein, G. et al. From whole-slide image to biomarker prediction: end-to-end weakly supervised deep learning in computational pathology. Nat Protoc 20, 293–316 (2025). https://www.nature.com/articles/s41596-024-01047-2
Polaris™ Breast
Our first diagnostic assesses metastatic risk in early breast cancer directly from digitized histology slides, helping refine adjuvant treatment options. The scientific foundation of Polaris™ Breast has been validated on more than 6,000 patients2 and is available for research use only while undergoing regulatory approval in the EU and US.
2. Boehm, K.M., El Nahhas, O.S.M., Marra, A. et al. Multimodal histopathologic models stratify hormone receptor-positive early breast cancer. Nat Commun 16, 2106 (2025). https://www.nature.com/articles/s41467-025-57283-x
News
PREVIOUS
NEXT
We are hiring!
Check out our open positions
Careers